Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy, EMLA cream, and lidocaine spray for pain reduction during arteriovenous fistula puncture
IRCT20200429047244N2Phase 3Completed
- Sponsor
- University of Baghdad
- Start
- Feb 2022
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of lidocaine and lidocaine + prilocaine in kidney failure and arteriovenous fistula (AVF) (3 arms), sponsored by University of Baghdad. Primary endpoint: Pain intensity during arteriovenous fistula puncture. Started Feb 2022; status: completed.
02
Drugs
lidocainelidocaine + prilocaine
03
Conditions
kidney failurearteriovenous fistula (AVF)
Beyond the preview
Go deeper on IRCT20200429047244N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200429047244N2.